UPDATE: Stifel Starts HilleVax, Inc. (HLVX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
UPDATE: JPMorgan Starts HilleVax, Inc. (HLVX) at Overweight
May 24, 2022 3:36 AM EDT(Updated - May 24, 2022 5:17 AM EDT)
JPMorgan analyst Eric Joseph initiates coverage on HilleVax, Inc. (NASDAQ: HLVX) with a Overweight rating and a price target of $24.00.
The analyst comments "We are Overweight rated on HLVX shares. Acute gastroenteritis due to norovirus infection posed a... More
